Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Infect Dis J ; 12(6): 466-73, 1993 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8345978

RESUMO

This prospective multicenter study was conducted to define more clearly clinical and laboratory criteria that predict a strong probability of occult bacteremia and to evaluate the effect of empiric broad spectrum antimicrobial treatment of these children. Children 3 to 36 months old with fever > or = 40 degrees C (104 degrees F) or, > or = 39.5 degrees C (103 degrees F) with white blood cells (WBC) > or = 15 x 10(9)/liter, and no focus of infection had blood cultures obtained and were randomized to treatment with oral amoxicillin/potassium clavulanate or intramuscular ceftriaxone. Sixty of 519 (11.6%) study patients had positive blood cultures: Streptococcus pneumoniae, 51; Haemophilus influenzae b, 6; Neisseria meningitidis, 2; and Group B Streptococcus, 1. Subgroups of high risk were identified as fever > or = 39.5 degrees C and WBC > or = 15 x 10(9)/liter, 55 of 331 or 16.6% positive with increasing incidence of positive culture with increasing increments of degrees of leukocytosis to WBC > or = 30 x 10(9)/liter where 9 of 21 or 42.9% were positive. Subgroups of significantly lower risk were identified as fever > or = 39.5 degrees C and WBC < 15 x 10(9)/liter, 5 of 182 or 2.7% positive and those with WBC < 10 x 10(9)/liter, 0 of 99 or 0.0% positive. Children with positive cultures who received ceftriaxone were nearly all afebrile after 24 hours whereas a significant number who received amoxicillin/potassium clavulanate remained febrile. In the 459 culture-negative children more amoxicillin/potassium clavulanate-treated children developed diarrhea and had less improvement in clinical scores after 24 hours than ceftriaxone-treated children.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Bacteriemia/tratamento farmacológico , Ceftriaxona/uso terapêutico , Ácidos Clavulânicos/uso terapêutico , Administração Oral , Amoxicilina/administração & dosagem , Combinação Amoxicilina e Clavulanato de Potássio , Antibacterianos/administração & dosagem , Ceftriaxona/administração & dosagem , Pré-Escolar , Ácidos Clavulânicos/administração & dosagem , Quimioterapia Combinada/administração & dosagem , Quimioterapia Combinada/uso terapêutico , Feminino , Febre , Seguimentos , Infecções por Haemophilus/tratamento farmacológico , Humanos , Lactente , Injeções Intramusculares , Leucocitose , Masculino , Infecções Meningocócicas/tratamento farmacológico , Análise Multivariada , Infecções Pneumocócicas/tratamento farmacológico , Estudos Prospectivos , Análise de Regressão , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...